University Hospital and New Jersey Medical School (NJMS) are, through their joint FDA-approved convalescent plasma program, collecting plasma donations from patients who have recovered from COVID-19 and infusing it into patients still struggling to fight off the virus. Marc Klapholz, chair of NJMS” Department of Medicine and the hospital’s chief of medical service, explains that the presumed antibodies in the plasma may improve seriously ill patients’ chances for survival. To read the full article.
Recent Posts
- Public Health Expert on Social Media’s Impact on Teens.
- On the Front Lines of Suicide Prevention Stand Family and Friends.
- Professors Weigh in on the Obesity Breakthrough of Ozempic and Similar Drugs.
- Rutgers Recruiting Young Adult Participants to Study Cigarillo Marketing and Smoking Behaviors.
- Decoding Early Lyme Disease.
Categories
- Community (1,984)
- Covid (974)
- CTO Events (1)
- News (2,530)
- Pilots (20)